Pure Extracts Technologies Stock Cash And Equivalents
| PRXTFDelisted Stock | USD 0.01 0.00 0.00% |
Pure Extracts Technologies fundamentals help investors to digest information that contributes to Pure Extracts' financial success or failures. It also enables traders to predict the movement of Pure Pink Sheet. The fundamental analysis module provides a way to measure Pure Extracts' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pure Extracts pink sheet.
Pure |
Pure Extracts Technologies Company Cash And Equivalents Analysis
Pure Extracts' Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Pure Extracts Cash And Equivalents | 245.08 K |
Most of Pure Extracts' fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pure Extracts Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Pure Extracts Technologies has 245.08 K in Cash And Equivalents. This is 99.97% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The cash and equivalents for all United States stocks is 99.99% higher than that of the company.
Pure Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pure Extracts' direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Pure Extracts could also be used in its relative valuation, which is a method of valuing Pure Extracts by comparing valuation metrics of similar companies.Pure Extracts is currently under evaluation in cash and equivalents category among its peers.
Pure Fundamentals
| Return On Equity | -1.39 | |||
| Return On Asset | -0.41 | |||
| Profit Margin | (2.64) % | |||
| Operating Margin | (2.48) % | |||
| Current Valuation | 2.58 M | |||
| Shares Outstanding | 116.77 M | |||
| Shares Owned By Insiders | 1.18 % | |||
| Price To Book | 0.98 X | |||
| Price To Sales | 0.57 X | |||
| Revenue | 1.23 M | |||
| Gross Profit | (285.02 K) | |||
| EBITDA | (4.34 M) | |||
| Net Income | (5.24 M) | |||
| Cash And Equivalents | 245.08 K | |||
| Total Debt | 1.43 M | |||
| Debt To Equity | 0.38 % | |||
| Current Ratio | 1.25 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (2.8 M) | |||
| Earnings Per Share | (0.05) X | |||
| Beta | 3.5 | |||
| Market Capitalization | 1.3 M | |||
| Total Asset | 6.32 M | |||
| Net Asset | 6.32 M |
About Pure Extracts Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pure Extracts Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pure Extracts using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pure Extracts Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Pure Pink Sheet
If you are still planning to invest in Pure Extracts Techno check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pure Extracts' history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |